InfoPack

Recent JCP Articles on InfoPack

Optimizing Treatment With Aripiprazole Monohydrate: Pharmacokinetic Advantages of Long-Acting Injectable Formulations, A Consensus Panel Report

Academic Highlights

Optimizing Treatment With Aripiprazole Monohydrate: Pharmacokinetic Advantages of Long-Acting Injectable Formulations, A Consensus Panel Report

June 13, 2025

A consensus panel reviews the pharmacokinetic advantages and clinical utility of long-acting injectable aripiprazole monohydrate to optimize treatment for schizophrenia and bipolar I disorder.

Joseph F. Goldberg , Eric D. Achtyes , Christoph U. Correll , et al

What Clinicians Should Know About the Pragmatic Use of Xanomeline-Trospium Combination

ASCP Corner

What Clinicians Should Know About the Pragmatic Use of Xanomeline-Trospium Combination

June 9, 2025

This article will help familiarize clinicians with practical issues in the use of xanomeline-trospium and its entry into the pharmacopoeia for schizophrenia.

Joseph F. Goldberg , Peter J. Weiden

Administering Semaglutide With Long-Term Olanzapine Use

Case Report

Administering Semaglutide With Long-Term Olanzapine Use

June 9, 2025

This report describes use of the GLP-1R agonist semaglutide in a patient with schizophrenia and severe, olanzapine-induced weight gain that was resistant to alternative treatments.

Francesca L. Ricciardi , Jayda L. Melnitsky , Shannon B. Peleg , et al

Recent PCC Articles on InfoPack

Community-Based Alternatives in Behavioral Crisis Transport

Letter to the Editor

Community-Based Alternatives in Behavioral Crisis Transport

June 12, 2025

Law enforcement transport for individuals in behavioral health crises results in significant financial costs and psychological trauma, reinforcing criminalization and stigma while worsening mental health conditions.

Kaushal Shah , Sahil Munjal

Recognizing Cotard Syndrome in the ED

Case Report

Recognizing Cotard Syndrome in the ED

June 12, 2025

Cotard syndrome can increase a patient’s risk for self-harm, self-starvation, and suicide, so it is imperative that early recognition occurs, especially in the ED.

Monica A. Nava Frenier , Ashish Sharma , Jeana Benton

Efficacy of GLP-1 Agonists in Mental Disorders

Review Article

Efficacy of GLP-1 Agonists in Mental Disorders

June 10, 2025

Current evidence underscores the potential of GLP-1 receptor agonists as a novel therapeutic approach for certain psychiatric disorders, particularly AUDs, depression, and autism-related food behaviors.

Mohsan Ali , Ayesha Ahmed , Basim Ahmed Khan , et al

Featured InfoPack Research

Trust and Happiness Go Hand in Hand

news

Trust and Happiness Go Hand in Hand

June 13, 2025

A new meta-analysis reveals that trust is a huge driver of well-being, powering a cycle that boosts happiness across demographics.

Weekly Mind Reader: What Can’t GLP-1s Do?

news

Weekly Mind Reader: What Can’t GLP-1s Do?

June 13, 2025

This week we rethink what we know about GLP-1s (again), including what it might mean for people with schizophrenia.

Pre-Game Rituals Build Stronger Bonds Than The Game Itself

news

Pre-Game Rituals Build Stronger Bonds Than The Game Itself

June 12, 2025

The emotional peak for sports fans occurs before the game even starts, according to new research that sheds light on group connections.